Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

US Patent RE50267 · Granted Jan 14, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treatment for cystic fibrosis2025
Methods of treatment for cystic fibrosis2025
Methods of treating conditions related to the S1P1 receptor2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutica2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2023
Compounds useful in the treatment of autoimmune and inflammatory disorders2023
Methods of treatment for cystic fibrosis2022
Heterocyclic compounds for the treatment of arenavirus2022
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2022